Proteomic dataset for altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells

This article contains raw and processed data related to research published in “Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation” [1]. The data presented here was obtained with the application of a bioor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheta, Razan, Roux-Dalvai, Florence, Woo, Christina M., Fournier, Frédéric, Bourassa, Sylvie, Bertozzi, Carolyn R., Droit, Arnaud, Bachvarov, Dimcho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908283/
https://www.ncbi.nlm.nih.gov/pubmed/27331112
http://dx.doi.org/10.1016/j.dib.2016.05.060
Descripción
Sumario:This article contains raw and processed data related to research published in “Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation” [1]. The data presented here was obtained with the application of a bioorthogonal chemical reporter strategy analyzing differential glycoprotein expression following the knock-down (KD) of the GALNT3 gene in the epithelial ovarian cancer (EOC) cell line A2780s. LC-MS/MS mass spectrometry analysis was then performed and the processed data related to the identified glycoproteins show that several hundred proteins are differentially expressed between control and GALNT3 KD A2780s cells. The obtained data also uncover numerous novel glycoproteins; some of which could represent new potential EOC biomarkers and/or therapeutic targets.

Ejemplares similares